Get the Stockscreener App
9.43
2.61%
0.24
89 Bio Inc stock is traded at $9.43, with a volume of 1.29M.
It is up +2.61% in the last 24 hours and down -5.51% over the past month.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$9.19
Open:
$9.28
24h Volume:
1.29M
Relative Volume:
0.71
Market Cap:
$1.40B
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-4.7868
EPS:
-1.97
Net Cash Flow:
$-165.54M
1W Performance:
+2.17%
1M Performance:
-5.51%
6M Performance:
-14.74%
1Y Performance:
+11.33%
1-Day Range:
$9.18
$9.70
1-Week Range:
$8.82
$9.70
52-Week Range:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Name
89 Bio Inc
Sector
Industry
Phone
(415) 432-9270
Address
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Compare ETNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
9.43 | 1.40B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-14-25 | Initiated | Goldman | Neutral |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Apr-22-24 | Resumed | BofA Securities | Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-10-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-23 | Initiated | UBS | Buy |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| May-12-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-26-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Resumed | BTIG Research | Buy |
| May-25-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Apr-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-20 | Initiated | Raymond James | Strong Buy |
| Sep-25-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jul-23-20 | Initiated | BTIG Research | Buy |
| Jul-07-20 | Initiated | Chardan Capital Markets | Buy |
| Dec-09-19 | Initiated | BofA/Merrill | Neutral |
| Dec-09-19 | Initiated | Oppenheimer | Outperform |
| Dec-09-19 | Initiated | RBC Capital Mkts | Outperform |
| Dec-09-19 | Initiated | SVB Leerink | Outperform |
View All
89 Bio Inc Stock (ETNB) Latest News
Exit strategy if you’re trapped in 89bio Inc.IPO Watch & Weekly Market Pulse Alerts - Newser
Leading vs lagging indicators on 89bio Inc. performanceJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - Newser
What Fibonacci levels say about 89bio Inc. reboundMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Evaluating 89bio Inc. with trendline analysisVolume Spike & Long-Term Safe Investment Plans - Newser
Advanced analytics toolkit walkthrough for 89bio Inc.New Guidance & Safe Entry Trade Reports - Newser
Chart overlay techniques for tracking 89bio Inc.Trade Signal Summary & Daily Technical Forecast Reports - Newser
Top chart patterns to watch in 89bio Inc.Fed Meeting & Reliable Price Breakout Signals - Newser
Can trapped investors hope for a rebound in 89bio Inc.M&A Rumor & Technical Entry and Exit Alerts - Newser
What high frequency data says about 89bio Inc.2025 Price Action Summary & Reliable Price Breakout Alerts - Newser
Smart tools for monitoring 89bio Inc.’s price action2025 Support & Resistance & Low Risk High Reward Trade Ideas - Newser
89bio, Inc. (ETNB) Reports Second-Quarter Results; Leerink Partners and Citi Maintain ‘Buy’ Ratings - MSN
Ichimoku Cloud Indicates Uncertainty Around 89bio Inc.July 2025 Sentiment & Weekly High Return Stock Opportunities - newsimpact.co.kr
Does 89bio Inc. have a sustainable dividendEarnings Recap Summary & Free Daily Entry Point Trade Alerts - classian.co.kr
Using Bollinger Bands to evaluate 89bio Inc.2025 Volume Leaders & Weekly Return Optimization Alerts - Newser
How to track smart money flows in 89bio Inc.July 2025 Drop Watch & Real-Time Volume Analysis - Newser
Recovery Signals Appearing in 89bio Inc. ChartsFed Meeting & Real-Time Volume Spike Alerts - beatles.ru
89bio Inc. Testing Reversal Zone on Weekly ChartSwing Trade & Low Risk High Win Rate Stock Picks - metrotimes.co.kr
89bio Inc. recovery potential after sell offQuarterly Earnings Summary & Intraday High Probability Setup Alerts - Newser
Quantitative breakdown of 89bio Inc. recent move2025 Top Decliners & Daily Entry Point Alerts - Newser
What moving averages say about 89bio Inc.Weekly Stock Report & Fast Moving Trade Plans - Newser
RSI Crosses Above 30 for 89bio Inc. — Reversal in SightJuly 2025 Decliners & Real-Time Market Sentiment Reports - newsyoung.net
What institutions are buying 89bio Inc. stock now2025 Stock Rankings & Expert Approved Momentum Ideas - Newser
What makes 89bio Inc. stock price move sharplyJuly 2025 Selloffs & Smart Investment Allocation Insights - Newser
How moving averages guide 89bio Inc. tradingPortfolio Value Report & Consistent Income Trade Recommendations - Newser
Chart based exit strategy for 89bio Inc.Market Activity Report & Low Risk Growth Stock Ideas - Newser
Signal strength of 89bio Inc. stock in tech scannersExit Point & Stepwise Trade Signal Guides - Newser
How to read the order book for 89bio Inc.July 2025 Breakouts & Verified Entry Point Signals - Newser
89Bio Inc. Faces Financial Uncertainty Amid Potential U.S. Tax Law Changes - TipRanks
How 89bio Inc. stock performs during market volatilityChart Pattern Strategy with ROI Focus - Newser
89 Bio Inc Stock (ETNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):